Lifevantage/$LFVN
1D1W1MYTD1Y5YMAX
Capital at risk
About Lifevantage
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product. Geographically, its products are sold in the regions of in the United States, Mexico, Canada, Japan, Taiwan, Thailand, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, Austria, Spain, Ireland, Belgium and Others. The company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operate in an integrated manner.
- Ticker
- $LFVN
- Sector
- Consumer Essentials
- Primary listing
- NASDAQ
- Employees
- 216
- Headquarters
- Lehi, United States
- Website
- www.lifevantage.com
Lifevantage Metrics
BasicAdvanced
$77M
15.43
$0.40
0.76
$0.19
3.24%
Price and volume
Market cap
$77M
Beta
0.76
52-week high
$11.72
52-week low
$3.90
Average daily volume
56K
Dividend rate
$0.19
Financial strength
Current ratio
1.893
Quick ratio
0.954
Long term debt to equity
23.618
Total debt to equity
29.379
Dividend payout ratio (TTM)
46.21%
Interest coverage (TTM)
136.73%
Profitability
EBITDA (TTM)
9.473
Gross margin (TTM)
77.56%
Net profit margin (TTM)
2.78%
Operating margin (TTM)
3.67%
Effective tax rate (TTM)
16.39%
Revenue per employee (TTM)
$850,000
Management effectiveness
Return on assets (TTM)
6.25%
Return on equity (TTM)
14.87%
Valuation
Price to earnings (TTM)
15.425
Price to revenue (TTM)
0.424
Price to book
2.29
Price to tangible book (TTM)
2.56
Price to free cash flow (TTM)
11.594
Free cash flow yield (TTM)
8.62%
Free cash flow per share (TTM)
0.532
Dividend yield (TTM)
3.00%
Forward dividend yield
3.24%
Growth
Revenue change (TTM)
-20.10%
Earnings per share change (TTM)
-46.67%
3-year revenue growth (CAGR)
-5.07%
10-year revenue growth (CAGR)
-1.23%
3-year earnings per share growth (CAGR)
25.99%
10-year earnings per share growth (CAGR)
-0.49%
3-year dividend per share growth (CAGR)
13.96%
What the Analysts think about Lifevantage
Analyst ratings (Buy, Hold, Sell) for Lifevantage stock.
Analyst projections of the future price of Lifevantage stock.
Lifevantage Financial Performance
Revenues and expenses
Lifevantage Earnings Performance
Company profitability
Upcoming events
Lifevantage News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.